Overview

Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis

Status:
Withdrawn
Trial end date:
2012-02-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the efficacy and safety of four doses of PRO-118 ophthalmic solution ophthalmic solution compared with placebo, for the treatment of seasonal (SAC) and perennial (PAC) allergic conjunctivitis.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Laboratorios Sophia S.A de C.V.
Treatments:
Ophthalmic Solutions
Pharmaceutical Solutions
Criteria
Inclusion Criteria:

- Patients with diagnosis of seasonal or perennial allergic conjunctivitis.

- Age ≥ 6 years old at screening visit.

- Male or female patients.

Applicable in patients ≥ 18 years old.

- Patient has signed the Informed Consent Form (ICF) prior to any screening procedures.

Applicable in patients with age ≤ 18 years old.

- Patients Patients'parents or legal guardians signed an Informed Consent Form (ICF).

- The patients also provided written assent.

Exclusion Criteria:

- Presence of any form of allergic conjunctivitis other than seasonal or perennial
allergic conjunctivitis (Atopic keratoconjunctivitis, giant papillary conjunctivitis).

- Any other ophthalmic medication within seven days prior to randomization.

- Patient with one blind eye.

- Visual acuity of 20/40 in any eye.

- Patients with history of active stage of any other concomitant ocular disease.

- Contraindications or sensitivity to any component of the study treatments.

- Contact lens users.

- Ocular surgery within the past 3 months.

- Women who were not using an effective means of contraception or who were pregnant or
nursing.

- Participation in any studies of investigational drugs within 90 days previous to the
inclusion.

Discontinuation criteria:

- Patients could be discontinued before the completion of the study because of use of
prohibited medications, adverse events, pregnancy, protocol violations, lack of
efficacy, or administrative reasons.